Page 76 - 2020Taiwan Food and Drug Administration Annual Report
P. 76

4FDUJPO   c&YQBOE UIF *OUFSOBUJPOBM $PPQFSBUJPO PO

                                   .FEJDBM %FWJDFT

                  Introduction of the Policy
                  Introduction of the Polic   y

                       TFDA has been committed to promoting international cooperation on medical devices
                  over the years and actively participating in international organizations to strive for hosting
                  international conferences and activities, to enhance Taiwan's international participation and
                  LQÀXHQFH  DV ZHOO DV WR FUHDWH DQ LQWHUQDWLRQDOL]HG UHJXODWRU\ HQYLURQPHQW IRU PHGLFDO GHYLFHV
                  In 2019, the implementation priorities include applying for conducting a pilot workshop of the
                  Regulatory Science Training Center of Excellence (CoE) for medical devices, participating
                  in IMDRF regulatory affairs, promoting the fulfillment of the cooperation framework

                  between Taiwan and Japan on medical products regulation, and strengthening the regulatory
                  communication on medical products with ASEAN countries.



                  Implementation Strategy
                  Implementation Strate    gy
                  I.  Hold the APEC Medical Devices Regulatory Science Center of Excellence
                     Pilot Workshop
                       At the end of 2018, TFDA applied to APEC Life Sciences Innovation Forum’s Regulatory
                  Harmonization Steering Committee (APEC LSIF-RHSC) for conducting a pilot workshop

                  of the Regulatory Science Training Center of Excellence (CoE) for medical devices and the
                  application was approved by the RHSC on March 21, 2019. The “2019 APEC Medical Devices
                  Regulatory Science Center of Excellence Pilot Workshop” was held from October 22 through
                  24, 2019 (Figure 5-3), to share principles and experience for evaluating medical device safety
                  and effectiveness with international standards. TFDA also conducted activities such as keynote
                  speeches, group discussions, case studies, and factory visit.

                  II.  Strive to join the IMDRF Working Group and continue to send staff to
                     participate in the annual meeting
                       The International Medical Device Regulators Forum (IMDRF) is a voluntary international
                  organization consisted of global medical device regulatory agencies. With the approval of
                  IMDRF Management Committee in June 2019 and as a representative of Asian Harmonization

                  Working Party (AHWP), TFDA became a member of the Principles of IVD Medical Devices
                  &ODVVL¿FDWLRQ :RUNLQJ *URXS WR SDUWLFLSDWH LQ WKH GHYHORSPHQW RI UHOHYDQW JXLGDQFH  ,Q DGGLWLRQ
                  TFDA also represented APEC to join IMDRF Management Committee meetings in March and
                  September of 2019 and reported the work progress of APEC during open forum.





            74
   71   72   73   74   75   76   77   78   79   80   81